In addition to our knowledge, we found one of the molecular mechanisms of SVIP-controlled PTENwt-dependent IGFBP-2 regulation in glioma, which provides the basis for IGFBP-2 as a marker indicating PTEN status, tumor progression, recurrence and survival of high-grade glioma. This evidence concerns the gene IGFBP2 and central nervous system cancer.